Evidence map›Paper›PMID 22244333›Full record

ArticleMolecular cell2012

Ars2 promotes proper replication-dependent histone mRNA 3' end formation.

Joshua J Gruber, Scott H Olejniczak, Jeongsik Yong, Gaspare La Rocca, Gideon Dreyfuss, Craig B Thompson

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Intrinsically disordered proteins SAID1/2 condensate on SERRATE for dual inhibition of miRNA biogenesis in Arabidopsis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Joshua J GruberAbramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA.
Scott H Olejniczak
Jeongsik Yong
Gaspare La Rocca
Gideon Dreyfuss
Craig B Thompson
Memorial Sloan Kettering Cancer Center · USHoward Hughes Medical Institute · USCancer Research Institute · US

Funding

TRANSLATIONAL CONTROL IN ADAPTATION TO HYPOXIAP01CA104838 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DIEHL, JOHN ALAN · 2004 to 2018
$17.6M
Cancer cell survival during factor deprivationR01CA105463 · NCI · UNIVERSITY OF PENNSYLVANIA · PI THOMPSON, CRAIG B · 2004 to 2013
$3.2M
NCI NIH HHS P01 CA104838NCI NIH HHS R01 CA105463
6 · The paper itself

Abstract

Ars2 is a component of the nuclear cap-binding complex that contributes to microRNA biogenesis and is required for cellular proliferation. Here, we expand on the repertoire of Ars2-dependent microRNAs and determine that Ars2 regulates a number of mRNAs, the largest defined subset of which code for histones. Histone mRNAs are unique among mammalian mRNAs because they are not normally polyadenylated but, rather, are cleaved following a 3' stem loop. A significant reduction in correctly processed histone mRNAs was observed following Ars2 depletion, concurrent with an increase in polyadenylated histone transcripts. Furthermore, Ars2 physically associated with histone mRNAs and the noncoding RNA 7SK. Knockdown of 7SK led to an enhanced ratio of cleaved to polyadenylated histone transcripts, an effect dependent on Ars2. Together, the data demonstrate that Ars2 contributes to histone mRNA 3' end formation and expression and these functional properties of Ars2 are negatively regulated by interaction with 7SK RNA.

Indexed as

RNA 3' End ProcessingHeLa CellsHistonesHumansMethyltransferasesMicroRNAsNuclear ProteinsRNA InterferenceRNA, MessengerRNA, Small InterferingHistonesMePCE protein, humanMethyltransferasesMicroRNAsNuclear ProteinsRNA, MessengerRNA, Small InterferingSRRT protein, human

Identifiers

PMID22244333
PMCPMC3269315
OpenAlexW1995687414

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.